Skip to main content
. 2019 Dec 10;7:e8188. doi: 10.7717/peerj.8188

Table 3. Number of patients in the non-RASBs group receiving antihypertensive drugs.

Antihypertensive agent Patients, n(%)
CCBs 359 (77.9)
Levamlodipine 149 (32.3)
Nitrendipine 69 (15.0)
Amlodipine 61 (13.2)
Nifedipine 57 (12.4)
Felodipine 13 (2.8)
Laxidipine 4 (0.9)
Lekadipine 2 (0.4)
Benidipine 1 (0.3)
Kalodipine 1 (0.3)
Nimodipine 1 (0.3)
Diuretics 30 (6.5)
Beta-blockers 11 (2.4)
Drug combination 37 (8.0)
Other drugs 24 (5.2)